The purpose of this paper was to compare mutation analysis results of formalin-fixed paraffin-embedded (FFPE) lung tumors obtained using 2 real-time PCR based methods and 2 next-generation sequencing (NGS) platforms with those obtained by high resolution melting followed by Sanger sequencing.
Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
Hinrichs JW, Marja van Blokland WT, Moons MJ, Radersma RD, Radersma-van Loon JH, de Voijs CM, Rappel SB, Koudijs MJ, Besselink NJ, Willems SM, de Weger RA
Purpose
Conclusion
All 14 Kirsten rat sarcoma viral oncogene homolog (KRAS) and 7 epidermal growth factor receptor (EGFR) mutations identified using high-resolution melting followed by Sanger sequencing were also identified using next generation sequencing using the Ion Torrent on the Personal Genome Machine (NGS-IonT), but 4 KRAS mutations failed to sequence using the 454 Genome Sequencer junior (NGS-454), 2 EGFR mutations were not included in the real-time PCR based COBAS z 480 (COBAS) and one of these EGFR mutations was not included in the real-time PCR based Rotor-Gene (RotorG). Interestingly, NGS-IonT, RotorG, and COBAS identified 1 specimen with a mutation in EGFR and another with a mutation in KRAS that were not found by high-resolution melting followed by Sanger sequencing. COBAS classified one additional specimen as containing a KRAS mutation, but this was not found using any other platform.
Studies (1)
Purpose
The purpose of this study was to compare mutation analysis results of 25 FFPE lung tumors using 2 real-time PCR based methods (RotorG and COBAS) and 2 NGS platforms (NGS-454 and NGS-IonT) with those obtained using high resolution melting followed by Sanger sequencing. DNA was extracted from sections of twenty-five FFPE non-small cell lung carcinoma (NSCLC) specimens using a modification of the DNeasy tissue kit or the COBAS DNA sample preparation kit (for COBAS analysis only). High-resolution melting combined with Sanger sequencing served as the reference method.
Summary of Findings
All 14 KRAS mutations identified using high-resolution melting followed by Sanger sequencing were also identified using the real-time PCR based COBAS and RotorG methods and by next generation sequencing using the NGS-IonT, but 4 of these samples failed to sequence using NGS-454. 9 of the 11 specimens identified as KRAS wild-type using high-resolution melting followed by Sanger sequencing were determined to be wild-type on all platforms. One of the 2 specimens with discrepant KRAS results was determined to be pG12X/p.G13X using COBAS, but wild-type using the other 3 platforms and the other was found to be p.G12V using NGS-IonT and RotorG, pG12X/p.G13X using COBAS and failed to sequence using NGS-454. All 7 EGFR mutations identified using high-resolution melting followed by Sanger sequencing were also found using NGS-454 and NGS-IonT, but 1 was not included in the COBAS analysis, and another was not included in the RotorG or COBAS analysis resulting in a wild-type classification. 18 specimens were classified as EGFR wild-type by Sanger sequencing. Of these, 4 failed using NGS-454 and 1 was classified as p.G719A using NGS-IonT, COBAS and RotorG.
Biospecimens
TissueLungPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
DNASNP assayDNANext generation sequencingDNADNA sequencingDNAReal-time qPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) SNP assay Specific Targeted nucleic acid EGFR exons 19, 20 and 21KRAS exons 2 and 3SNP assay Specific Technology platform 454 Genome Sequencer juniorCOBAS z 480 analyzerHigh resolution melting with Sanger sequencingIon Torrent Personal Genome MachineRotor-Gene Q